Mr Bruce Pritchard
Chair of Court BA, CA
Biography
An accountant by training, Bruce has spent over two decades working in the life sciences and pharmaceutical industry. He has more than fourteen years' experience with Liminal BioSciences and has held a number of senior global positions across the organisation.
Prior to being appointed CEO with Liminal, he became COO in 2014; previously, he was the Group CFO, a role he had held since 2008. Bruce brings a proven track record of success in strategic acquisitions and in raising debt and equity finance.
As well as being a chartered accountant, Bruce has many years of experience in general management and operations. Prior to joining Liminal, Bruce worked as a senior director for CV Therapeutics, an NASDAQ listed biopharmaceutical company.
Bruce is a graduate of Heriot-Watt University where he gained a BA in Accountancy and Computer Science. He is a member of the Institute of Chartered Accountants of Scotland and a Fellow of the Institute of Directors. He is also Chair of Board of Porton Biopharma Limited the Chair of Court at Heriot-Watt University. He was recently President of The Institute of Chartered Accountants of Scotland.